Vigabatrin in Epilepsy Related to TSC: Does it PREVeNT AND OR (EPI) STOP Seizures OR… Do We Need Some More STEPS as VI RAP?
作者信息
Joshi Charuta
机构信息
Division of Pediatric Neurology, Department of Pediatrics, University of Texas Southwestern Medical Center.
出版信息
Epilepsy Curr. 2024 Jan 10;24(2):87-89. doi: 10.1177/15357597231225097. eCollection 2024 Mar-Apr.
Abstract
摘要
相似文献
1
Vigabatrin in Epilepsy Related to TSC: Does it PREVeNT AND OR (EPI) STOP Seizures OR… Do We Need Some More STEPS as VI RAP?丙戊酸用于与结节性硬化症相关的癫痫：它能预防和/或（癫痫）终止发作吗？或者……我们是否需要像VI RAP那样采取更多措施？
Epilepsy Curr. 2024 Jan 10;24(2):87-89. doi: 10.1177/15357597231225097. eCollection 2024 Mar-Apr.
2
Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex.氨己烯酸可抑制结节性硬化症模型小鼠的癫痫发作和 mTOR 通路激活。
PLoS One. 2013;8(2):e57445. doi: 10.1371/journal.pone.0057445. Epub 2013 Feb 20.
3
Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.结节性硬化症患儿的癫痫：缓解几率及对抗癫痫药物的反应
Epilepsia. 2015 Aug;56(8):1239-45. doi: 10.1111/epi.13050. Epub 2015 Jun 4.
4
Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.《结节性硬化症相关癫痫的药物治疗》
CNS Drugs. 2021 Sep;35(9):965-983. doi: 10.1007/s40263-021-00835-8. Epub 2021 Aug 21.
5
Tuberous sclerosis complex and epilepsy in infancy: prevention and early diagnosis.结节性硬化症复合体与婴儿期癫痫：预防与早期诊断
Arch Pediatr. 2022 Dec;29(5S):5S8-5S13. doi: 10.1016/S0929-693X(22)00284-6.
6
Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry.结节性硬化症相关癫痫的诊断、治疗及预后的历史模式：来自TOSCA注册研究的结果
Front Neurol. 2021 Sep 8;12:697467. doi: 10.3389/fneur.2021.697467. eCollection 2021.
7
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial.EPISTOP 试验中婴儿结节性硬化症的癫痫预防。
Ann Neurol. 2021 Feb;89(2):304-314. doi: 10.1002/ana.25956. Epub 2020 Nov 27.
8
Overview of therapeutic options for epilepsy.癫痫治疗选择概述。
Arch Pediatr. 2022 Dec;29(5S):5S14-5S19. doi: 10.1016/S0929-693X(22)00285-8.
9
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.氨己烯酸早期治疗不能减少结节性硬化症的局灶性癫痫发作或改善认知功能：PREVeNT试验
Ann Neurol. 2023 Aug 28. doi: 10.1002/ana.26778.
10
Approach to Preventive Epilepsy Treatment in Tuberous Sclerosis Complex and Current Clinical Practice in 23 Countries.结节性硬化症预防性癫痫治疗方法及23个国家的当前临床实践
Pediatr Neurol. 2021 Feb;115:21-27. doi: 10.1016/j.pediatrneurol.2020.11.003. Epub 2020 Nov 5.
引用本文的文献
1
Developmental Outcome at 36 Months in Tuberous Sclerosis: Are There any Modifiable Predictors?结节性硬化症36个月时的发育结局：是否存在可改变的预测因素？
Epilepsy Curr. 2025 Jun 16:15357597251351453. doi: 10.1177/15357597251351453.
本文引用的文献
1
Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy.结节性硬化症相关癫痫管理的最新临床建议。
Eur J Paediatr Neurol. 2023 Nov;47:25-34. doi: 10.1016/j.ejpn.2023.08.005. Epub 2023 Aug 30.
2
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.氨己烯酸早期治疗不能减少结节性硬化症的局灶性癫痫发作或改善认知功能：PREVeNT试验
Ann Neurol. 2023 Aug 28. doi: 10.1002/ana.26778.
3
Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry.结节性硬化症相关癫痫的诊断、治疗及预后的历史模式：来自TOSCA注册研究的结果
Front Neurol. 2021 Sep 8;12:697467. doi: 10.3389/fneur.2021.697467. eCollection 2021.
4
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.更新后的国际结节性硬化症复合体诊断标准及监测与管理建议。
Pediatr Neurol. 2021 Oct;123:50-66. doi: 10.1016/j.pediatrneurol.2021.07.011. Epub 2021 Jul 24.
5
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial.EPISTOP 试验中婴儿结节性硬化症的癫痫预防。
Ann Neurol. 2021 Feb;89(2):304-314. doi: 10.1002/ana.25956. Epub 2020 Nov 27.
6
Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study.头皮 EEG 棘波预测 TSC 婴儿癫痫发作：一项纵向观察性研究。
Epilepsia. 2019 Dec;60(12):2428-2436. doi: 10.1111/epi.16379. Epub 2019 Nov 5.
7
Vigabatrin: Lessons Learned From the United States Experience.氨己烯酸：来自美国经验的教训。
J Neuroophthalmol. 2018 Dec;38(4):442-450. doi: 10.1097/WNO.0000000000000609.
8
Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis.在无癫痫发作的患者中停用抗癫痫药物后癫痫复发和长期结局的个体化预测模型：系统评价和个体参与者数据荟萃分析。
Lancet Neurol. 2017 Jul;16(7):523-531. doi: 10.1016/S1474-4422(17)30114-X. Epub 2017 May 5.
9
Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants.无症状结节性硬化症复合体婴儿即将发生癫痫的临床脑电图生物标志物
Pediatr Neurol. 2016 Jan;54:29-34. doi: 10.1016/j.pediatrneurol.2015.09.013. Epub 2015 Sep 25.
10
EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients - a prospective study of 5 patients.结节性硬化症患者癫痫发作前的脑电图异常——5例患者的前瞻性研究
Eur J Paediatr Neurol. 2014 Jul;18(4):458-68. doi: 10.1016/j.ejpn.2013.12.006. Epub 2013 Dec 31.
Zotero 插件